Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tremor in neuropathies of different origin.
White Matter Changes in Patients with Friedreich Ataxia after Treatment with Erythropoietin.
Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure.
Immune cell dynamics in the CNS: Learning from the zebrafish.
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
ZSTK474, a novel PI3K inhibitor, modulates human CD14(+) monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation.
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women With Multiple Sclerosis.
Glucocorticoid treatment of multiple sclerosis.
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
Multiple sclerosis: Grey matter atrophy in the thoracic spinal cord is associated with disability in patients with multiple sclerosis.
Multiple Sclerosis and Antibodies against KIR4.1.
Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.
Enriched CD161high CCR6+ γδ T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis.
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
Continuous evolution of magnetic resonance imaging in multiple sclerosis.
Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding.
Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.
The mechanisms of neurotoxicity and the selective vulnerability of nervous system sites.
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Pages
« first
‹ previous
…
483
484
485
486
487
488
489
490
491
…
next ›
last »